U.S., Aug. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07132086) titled 'Prospective Observational Study on the Effectiveness of Daridorexant in Chronic Insomnia in a Real-World Setting' on Aug. 09.

Brief Summary: The primary objectives of this study is to evaluate the real-world effectiveness of daridorexant 50 mg in improving both subjective (self-report) and objective (actigraphic) sleep parameters in patients with chronic insomnia.

The secondary aims of this study are:

* To compare the effectiveness of daridorexant 50 mg with other guideline-recommended therapies for chronic insomnia in improving sleep parameters and sleep health.

* To identify clinical and demographic predictors of response to da...